Terms: = Lymphoma AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
87 results:
1. [Expression and Prognostic Value of Cytokines in Patients with Newly Diagnosed Diffuse Large B-Cell lymphoma].
Man Y; Ge CQ; Li ZZ; Yang TH; Wang YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1050-1055. PubMed ID: 37551476
[TBL] [Abstract] [Full Text] [Related]
2. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes.
Bao C; Gu J; Huang X; You L; Zhou Z; Jin J
Cytokine; 2023 Sep; 169():156289. PubMed ID: 37453327
[TBL] [Abstract] [Full Text] [Related]
3. The genetic polymorphisms of immune-related genes contribute to the susceptibility and survival of lymphoma.
Gu C; Can C; Liu J; Wei Y; Yang X; Guo X; Wang R; Jia W; Liu W; Ma D
Cancer Med; 2023 Jul; 12(14):14960-14978. PubMed ID: 37329186
[TBL] [Abstract] [Full Text] [Related]
4. Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin lymphoma.
Yoon DH; Koh Y; Jung M; Kwak JE; Shin EC; Hwang YK; Kim WS
Transplant Cell Ther; 2023 Apr; 29(4):253.e1-253.e9. PubMed ID: 36610490
[TBL] [Abstract] [Full Text] [Related]
5. The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP era.
Ito A; Miyaoka M; Tomita S; Ikoma H; Hiraiwa S; Carreras J; Kikuti YY; Kawada H; Nakamura N
Pathol Int; 2022 Nov; 72(11):550-557. PubMed ID: 36218197
[TBL] [Abstract] [Full Text] [Related]
6. il-2/il-2R signaling and il-2Rα-targeted therapy in anaplastic large cell lymphoma.
Liang HC
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):25-30. PubMed ID: 36094651
[TBL] [Abstract] [Full Text] [Related]
7. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
Lind J; Hellinger R; Kudweis P; Moll HP; Gattringer J; Thell K; Edtmayer S; Gruber CW; Stoiber D; Kollmann K
Biomed Pharmacother; 2022 Sep; 153():113486. PubMed ID: 36076504
[TBL] [Abstract] [Full Text] [Related]
8. Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma.
Mizuno Y; Shibata S; Miyagaki T; Ito Y; Taira H; Omori I; Hisamoto T; Oka K; Matsuda KM; Boki H; Takahashi-Shishido N; Sugaya M; Sato S
J Dermatol; 2022 Nov; 49(11):1124-1130. PubMed ID: 35821652
[TBL] [Abstract] [Full Text] [Related]
9. Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone lymphoma.
Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
[TBL] [Abstract] [Full Text] [Related]
10. Genetically Driven CD39 Expression Affects Sezary Cell Viability and il-2 Production and Detects Two Patient Subsets with Distinct prognosis.
Picozza M; Cristofoletti C; Bresin A; Fioretti M; Sambucci M; Scala E; Monopoli A; Cantonetti M; Pilla MA; Accetturi MP; Borsellino G; D'Atri S; Caprini E; Russo G; Narducci MG
J Invest Dermatol; 2022 Nov; 142(11):3009-3019.e9. PubMed ID: 35533722
[TBL] [Abstract] [Full Text] [Related]
11. CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.
Perkins B; Showel M; Schoch L; Imus PH; Karantanos T; Yonescu R; Morsberger L; Ghiaur G; Gladstone DE; Jones RJ
Leuk Lymphoma; 2022 Jul; 63(7):1617-1623. PubMed ID: 35343368
[TBL] [Abstract] [Full Text] [Related]
12. Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma.
Li X; Liu M; Shi Q; Fang Y; Fu D; Shen ZX; Yi H; Wang L; Zhao W
Hematol Oncol; 2023 Apr; 41(2):230-238. PubMed ID: 35304777
[TBL] [Abstract] [Full Text] [Related]
13. Super-enhancer-based identification of a BATF3/il-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
Liang HC; Costanza M; Prutsch N; Zimmerman MW; Gurnhofer E; Montes-Mojarro IA; Abraham BJ; Prokoph N; Stoiber S; Tangermann S; Lobello C; Oppelt J; Anagnostopoulos I; Hielscher T; Pervez S; Klapper W; Zammarchi F; Silva DA; Garcia KC; Baker D; Janz M; Schleussner N; Fend F; Pospíšilová Š; Janiková A; Wallwitz J; Stoiber D; Simonitsch-Klupp I; Cerroni L; Pileri S; de Leval L; Sibon D; Fataccioli V; Gaulard P; Assaf C; Knörr F; Damm-Welk C; Woessmann W; Turner SD; Look AT; Mathas S; Kenner L; Merkel O
Nat Commun; 2021 Sep; 12(1):5577. PubMed ID: 34552066
[TBL] [Abstract] [Full Text] [Related]
14. Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.
Assis-Mendonça GR; Fattori A; Rocha RM; Lourenço GJ; Delamain MT; Nonogaki S; de Lima VCC; Colleoni GWB; de Souza CA; Soares FA; Lima CSP; Vassallo J
BMC Cancer; 2021 Mar; 21(1):209. PubMed ID: 33648463
[TBL] [Abstract] [Full Text] [Related]
15. The standardized uptake value calculated from
Kume A; Toriihara A; Shimizu R; Harata N; Isogai J; Tanaka H
J Clin Exp Hematop; 2021 Mar; 61(1):29-34. PubMed ID: 33551439
[No Abstract] [Full Text] [Related]
16. Efficacy of different regimens in nasal NK/T-cell lymphoma and analysis of serum inflammation and prognosis of patients.
Zhang L; Huang Y; Wang Y
J BUON; 2020; 25(4):1997-2002. PubMed ID: 33099944
[TBL] [Abstract] [Full Text] [Related]
17. Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma.
Takeda A; Hasegawa E; Nakao S; Ishikawa K; Murakami Y; Hisatomi T; Arima M; Yawata N; Oda Y; Kimura K; Yoshikawa H; Sonoda KH
Sci Rep; 2020 Sep; 10(1):15715. PubMed ID: 32973297
[TBL] [Abstract] [Full Text] [Related]
18. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
Willerslev-Olsen A; Buus TB; Nastasi C; Blümel E; Gluud M; Bonefeld CM; Geisler C; Lindahl LM; Vermeer M; Wasik MA; Iversen L; Becker JC; Andersen MH; Gjerdrum LMR; Litvinov IV; Litman T; Krejsgaard T; Woetmann A; Ødum N
Blood Cancer J; 2020 May; 10(5):57. PubMed ID: 32409671
[TBL] [Abstract] [Full Text] [Related]
19. [Expression of p-AKT and p-mTOR in pediatric Burkitt lymphoma and their correlation with prognosis].
Man J; Chen L; Zhai XW; Ma YY; Wang HS; Qian XW; Feng JY; Zhao J; Cao P; Lu FJ
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):156-161. PubMed ID: 32074729
[No Abstract] [Full Text] [Related]
20. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract] [Full Text] [Related]
[Next]